HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors.

A new interesting article has been published in Elife. 2019 May 23;8. pii: e46344. doi: 10.7554/eLife.46344. and titled:

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors.

Authors of this article are:

Koneru PC, Francis AC, Deng N, Rebensburg SV, Hoyte AC, Lindenberger J, Adu-Ampratwum D, Larue RC, Wempe MF, Engelman AN, Lyumkis D, Fuchs JR, Levy RM, Melikyan GB, Kvaratskhelia M.

A summary of the article is shown below:

Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a promising new class of antiretroviral agents that disrupt proper viral maturation by inducing hyper-multimerization of IN. Here we show that lead pyridine-based ALLINI KF116 exhibits striking selectivity for IN tetramers versus lower order protein oligomers. IN structural features that are essential for its functional tetramerization and HIV-1 replication are also critically important for KF116 mediated higher-order IN multimerization. Live cell imaging of single viral particles revealed that KF116 treatment during virion production compromises the tight association of IN with capsid cores during subsequent infection of target cells. We have synthesized the highly active (-)-KF116 enantiomer, which displayed EC50 of ~7 nM against wild type HIV-1 and ~10-fold higher, sub-nM activity against a clinically relevant dolutegravir resistant mutant virus suggesting potential clinical benefits for complementing dolutegravir therapy with pyridine-based ALLINIs.© 2019, Koneru et al.

Check out the article’s website on Pubmed for more information:



This article is a good source of information and a good way to become familiar with topics such as: infectious disease; microbiology; viruses.